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CBA/N mice have an X-linked immunodeficiency  that primarily influences the function of 
bone marrow-derived precursors of antibody-forming cells or B cells  (1, 2). Animals bearing 
this defect fail to make a normal antibody response to a spectrum of thymus-independent (TI) 
antigens, TI-2; including the type III pneumococcal polysaccharide (SSS-III), but respond to 
TI-1 antigens (3). Although defective mice do not respond to phosphorycholine (PC) on TI-2- 
dependent or  TI  carriers,  the  activity of PC-specific helper T  cells  has  been shown  to  be 
inhibited by anti-HOPC-8 idiotype serum, suggesting that V-region-gene expression in T cells 
is intact (4). 
The serum antibody response to SSS-III is completely absent in defective mice; however, 
antigen-specific  suppressor T-cells (Ts) can be generated by prior treatment with extremely low 
doses  (5  ng)  of SSS-III (5). This emphatically demonstrates the  presence of V-region-gene 
products, capable of antigen-specific activation of either Ts or B cells in defective mice. To test 
whether B cells capable of anti-SSS-III  responses exist in these mice, hybridorrlas were produced 
between  plasmacytoma cells  and  spleen cells  from  immunized mice  bearing the  X-linked 
genetic defect  to determine whether antibody synthesis and secretion could be enhanced. 
Materials and Methods 
Animals.  8-wk-old BALB/c mice were  obtained from Cumberland View Farms, Clinton, 
Tenn.; 8-wk-old nonresponding (CBA/N  ×  BALB/c male)F1 (xid +, CB mice) and responding 
(BALB/c  ×  CBA/N male)Fx  (xid-, BC mice)  were obtained from the Division of Research 
Services,  National Institutes of Health, Bethesda, Md. Mice were bled from the retro-orbital 
plexus before killing and cell fusion for the measurement of serum antibody levels. 
Immunizations.  Mice were given an optimally immunogenic dose  (0.5/*g)  of SSS-III i.p.; 2 
d later, they were given 300/*g concanavalin A (Con A) i.p. in saline (6). Mice were killed 5 d 
after immunization. 
Cell Fusion.  Hybridomas were produced as  described by Margulies et  al.  (7)  with slight 
modifications (K. Jin Kim and K. R. Schroer.  Manuscript in preparation.). Pooled spleen-cell 
suspensions from  four  immunized mice  were  fused  with  polyethylene glycol  to  the  NS1 
plasmacytoma cell line of X63 (8). Fusion products were then cloned at a limiting dilution of 
5  2  ×  10  cultured spleen cells per well in 96-well plates (Costar, Data Packaging, Cambridge, 
Mass.). Culture supernates were assayed for antibody specific for SSS-III, at day 14, after fusion 
and subsequent culture. 
Antibody Assays.  Sera of immunized mice were tested for antibody specific for SSS-III by a 
125  modified Farr assay using 14% polyethylene glycol (mol wt, 6,000) to precipitate antibody-  I- 
SSS-III complexes. Cell-culture supernates were assayed for antibody by radioimmunometric 
binding of 12SI-anti-Fab,  (or  iodinated anti-/*, anti-a, anti-yl, or anti-y2) to  antigen-coated 
(SSS-III) polyvinyl  chloride flexible microtiter plates (Cooke Engineering  Co., Alexandria, Va.) 
(9). Binding in the radioimmunometric  assays was >95% inhibitable with SSS-III. 
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FIG.  1.  Pre-fusion analysis of the mice used for generation of hybridomas by titration of serum 
antibody for binding to I~sI-SSS-III.  Antigen-antibody complexes were precipitated by polyethylene 
glycol  6,000  at  14%  final  concentration.  No  detectable  antibody is  present  in  CB  sera  above 
background levels of nonspecific binding. 
Results  and  Discussion 
Serum antibody titers from immunized mice are compared in Fig. 1. Nonresponding 
CB mice bearing the X-linked genetic defect showed no detectable binding to SSS- 
III,  whereas  responding  BC  and  BALB/c mice  give rather  typical binding  curves 
(ABC 20:1/81-1/243). CB sera were shown by 125I-anti-Fab binding to contain <20 
ng/ml  of anti-SSS-III  antibody.  Thus,  significant  amounts  of antibody were  not 
detectable in the serum of defective mice. 
Spleen cells from hemizygous F1 male mice were then fused to plasmacytoma cells 
after the mice were immunized with SSS-III and treated with Con A to optimize any 
expression of B-cell activity (6).  The analysis of cell-culture supernatant  fluids from 
cloned fusion products for binding to SSS-III was performed at 14 d. At that time, all 
clones were grown continuously in the presence of HAT (hypoxanthine, aminopterin, 
thymidine)  to select for hybrids. This also ensures that  the X  chromosome derived 
from immunized spleen cells is present in the hybrid-cell heterokaryons because the 
X  chromosome (HGPRT  ÷, xid  ÷) from the spleen-cells population provides protection 
against  the lethal effects of HAT on parental myeloma cells, NSI  (HGPRT-, xid-). 
The analysis of positive and negative wells is shown in Table I  for anti-# specificity. 
Thus,  16 culture supernates gave binding comparable to levels obtained by specific 
dilutions of an affinity purified hybridoma standard  (IgM, •)  that  is maintained in 700  SCHROER  ET AL.  BRIEF  DEFINITIVE REPORT 
TABLE I 
Radioimmunometric Analysis of Hybridoma Supernates 
l~l-anti-# binding* 
Number of hybridoma wells 
CB (nonre-  BC (responder) 
sponder) 
Equivalent quantity of 
IgM anti-SSS-III:it: 
#pm 
< 1,000  143  66  <3 ng/ml 
1,000-5,000  4  1  -- 
5,000-10,000  1  0  100 ng/ml 
10,000-15,000  1  3  -- 
15,000-20,000  0  0  1 ~g/ml 
20,000-25,000  2  0  -- 
25,000-35,000  0  4  10/tg/ml 
* 0.010 ml of culture supernate from CB or BC mice hybridoma cultures were tested with 100,000 cpm '251- 
anti-# for solid-phase binding to plastic plates. 
:l: Affinity purified hybridoma (BALB/c, IgM, ~) anti-SSS-III (DB6-1). 
our laboratory.  Similar  analyses were performed for other  isotypes. The  frequency 
and isotype distribution  of the hybrids obtained is shown in Table II. Although  the 
numbers are small and the frequency distributions are difficult to compare, a striking 
finding is the presence of SSS-III-specific hybrids from nonresponder, defective mice. 
In fact, the amount of antibody detected in culture fluids from such hybrids ranged 
from  10 ng/ml to  10/tg/ml. This occurred despite the fact that serum antibody can 
not be detected in the serum of such mice before cell fusion (Fig.  1). 
The  frequency  of antigen-specific  fusion  products  from  nonimmunized  mice  is 
expected to be nearly zero.  For another antigen,  sheep erythrocyte  (SRBC),  it was 
thought highly unusual to obtain an antigen-specific frequency of 10% among hybrids 
making antibody specific for SRBC  as described  by Milstein  et al.  (8).  Thus,  they 
suggested that antigen-driven activation of B lymphocytes was the essential selective 
mechanism in generating a  high  fusion rate (10%).  A  5% frequency using CB mice 
suggests  that  antigen-driven  lymphocyte activation  is  indeed  occurring,  even  if no 
specific evidence for such  activation  (the presence of serum  antibody)  is evident  in 
vivo. This implies that the B cells of mice bearing the X-linked genetic defect possess 
antigen-specific  receptors  through  which  activation  occurs.  The  reason  why  such 
activation is not expressed as antibody synthesis in mice bearing the X-linked genetic 
defect  is  not  known,  although  there  are  several  possibilities.  If  an  intracellular 
mechanism for the assembly and/or export of immunoglobulin is defective, then the 
hybrid-partner cell  (the  NS1  plasma-cell tumor)  may be reconstituting  this  defect. 
This  would  imply the  existence of separate  pathways  for synthesis,  assembly, and 
secretion  of antibody when  B  cells are selected by TI-1  or TI-2 antigens.  Immune 
suppressive regulation of secretion seems to be an unlikely possibility because others 
have clearly shown that B-cell responses may be transferred adoptively into defective 
mice (5,  10). Furthermore, speculation (11,  12) that VH-gene expression is defective in 
conjunction  with  the  inability  to  elaborate  CH  genes  commonly  associated  with 
polysaccharides (i.e., IgM and IgG3) seems unlikely because all eight isolated hybrids 
were  IgM.  The  lack  of hybrids  of other  classes  should  be  interpreted  cautiously 
because the number was small. (IgG3 assays were not performed in this investigation.) 
Whatever the mechanisms involved, the ability to generate hybrids from mice having SCHROER  ET  AL.  BRIEF DEFINITIVE REPORT  701 
TABLE  II 
Frequency of Anti-SSS-lll-specific  Hybrids (Spleen* X  NSI Cells) 
Total num-  Number of clones with SSS-IlI-specific 
ber of hy-  antibody,:~ class:  Number 
Source of spleen cells  brids iso-  negative 
lated  #  a  ¥1  ¥2 
BALB/c  128  18  2  3  6  99 
BC (responder)  79  8  4  1  0  66 
CB (nonresponder)  151  8  0  0  0  143 
* Spleen cells were removed at day 5 after SSS-III and Con A stimulation. 
:~ Hybrids were examined for SSS-III-specific antibody secretion 14 d after fusion and plating at a limiting 
dilution. 
a  completely defective expressed repertoire to  particular antigens suggests  that  hy- 
bridization must be used carefully to evaluate the expressed vs. the potential repertoire 
of antibody-forming cells. 
Summary 
(CBA/N  X  BALB/c  male)F1 mice bear on  X-linked defect making them  totally 
unresponsive  to T-independent  (TI),  TI-2  antigens  such  as type III pneumococcal 
polysaccharide  (SSS-III). We  found  that  somatic  cell  hybrids  between  CB  nonre- 
sponder spleen cells and NS1  plasmacytoma cells secreted antibody specific for SSS- 
III.  The  solid-phase  binding  of  such  antibody  was  completely  inhibited  by  the 
addition of free antigen  (SSS-III) and  the amount  of antibody detected  in  culture 
fluids ranged from  10 ng/ml to 10 btg/ml. Eight hybridoma clones were identified; all 
make antibody of the IgM class. These results indicate that the X-linked defect does 
not result in a  deletion of a  B-cell subset which responds to TI-2 antigens. 
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